Clarification26 Aug 2026, 02:40 pm
GlaxoSmithKline Pharmaceuticals Ltd Clarifies Volume Increase
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd has responded to an inquiry regarding a significant increase in trading volume. The company stated that it has made all necessary disclosures as per SEBI regulations and has not withheld any material information. They clarified that the surge in volume is purely market-driven and reiterated their commitment to complying with listing regulations and informing the stock exchange of any price-sensitive information.
Key Highlights
- Company clarifies significant increase in security volume.
- All material information has been disclosed as per SEBI regulations.
- Volume increase is attributed to market-driven factors.
- Company reaffirms commitment to listing compliance.
Price Impact
More from GLAXO